@mcneese.chad Wasnt sure where this should go so move it if it makes sense
In certain pathological conditions (such as periodontitis), high levels of methyl mercaptan (MeSH) act as a competitive false substrate for SQOR, reacting with the enzyme to form persulfide products (MeSSH) that cannot be further metabolized
Reviews of New Drug Approval submissions to the FDA usually last one to two years before a drug is greenlit for manufacturing
The study also: Compared tirzepatide with phentermine rather than placebo Identified pain through diagnosis and prescription records Did not directly measure each patients pain severity Could not fully separate the effects of weight loss from medication-specific effects Could not prove that tirzepatide caused the reduction in pain encounters The findings support further research, but they are not enough to classify tirzepatide as a joint-pain or arthritis medication
Es vlida en cualquier farmacia de la UE, incluyendo Espaa, Portugal, Italia, Francia y Alemania
In many cases, yes especially if you have absorption issues
